Proxy Votes Now

Home › Funds › John Hancock › Small Company Value Trust

Small Company Value Trust (JAEPX) proxy voting record 2025-2026

Fund family: John Hancock · Filed by JOHN HANCOCK VARIABLE INSURANCE TRUST (CIK 756913) · SEC series S000008316

Share classes and tickers: JAEPX (C000022724), JAEQX (C000022723), JAERX (C000022725)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,777 with, 9 against, 49 abstentions (not counted as with management); 3 items carried no recommendation; 4 split votes are in neither count. Shareholder proposals: 1 FOR, 4 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with John Hancock as a whole

The same two figures as John Hancock’s manager page (290,519 ballot items across 99 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsJohn HancockItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)91.8%1,75990.1%242,172
Backed environmental and social shareholder proposals at US companiesn/a113.4%1,935

Where this fund voted differently from most John Hancock funds

Each ballot item this fund voted is set against the votes of the other John Hancock funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most John Hancock funds on 116 items (6.9% of the 1,675 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost John Hancock fundsMgmtResult
PINNACLE FINANCIAL PARTNERS, INC.2025-11-06A proposal to approve the adjournment or postponement of the Special Meeting to a later date or time, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment, there are not sufficient votes to approve the Pinnacle merger proposal or to ensure that any supAgainstFOR — 12 of 12 John Hancock fundsAgainst—
THE ENSIGN GROUP, INC.2026-05-13ELECTION OF CLASS I DIRECTORS EACH FOR A THREE-YEAR TERM as follows: Mr. Barry M. SmithAgainstFOR — 10 of 10 John Hancock fundsAgainstElected, 92.3% support
THE ENSIGN GROUP, INC.2026-05-13ELECTION OF CLASS I DIRECTORS EACH FOR A THREE-YEAR TERM as follows: Ms. Swati B. AbbottAgainstFOR — 10 of 10 John Hancock fundsAgainstElected, 93.1% support
COLUMBIA BANKING SYSTEM,INC.2025-07-21A proposal to adjourn the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes at the time of the Special Meeting to approve the share issuance proposal or to ensure that any supplement or amendment to the joint proxy statement/prospectus is tAgainstFOR — 10 of 10 John Hancock fundsAgainst—
SYNOVUS FINANCIAL CORP.2025-11-06To approve the adjournment or postponement of the Special Meeting to a later date or time, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment or postponement, there are not sufficient votes to approve the Merger Proposal, or to ensure that any suppleAgainstFOR — 10 of 10 John Hancock fundsAgainst—
MIAMI INTL HLDGS INC2026-06-16The approval, on a non-binding advisory basis, of the compensation of our named executive officers.ForAGAINST — 8 of 8 John Hancock fundsForPassed (calculated), 73.9% support
TXNM ENERGY, INC.2025-08-28Approve one or more adjournments of the special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the special meeting to approve the merger agreement.AgainstFOR — 7 of 7 John Hancock fundsAgainst—
TXNM ENERGY, INC.2025-08-28Approve, by non-binding, advisory vote, certain compensation arrangements for TXNM's named executive officers in connection with the merger contemplated by the merger agreement .AgainstFOR — 7 of 7 John Hancock fundsAgainst—
CASELLA WASTE SYSTEMS, INC.2026-06-04To elect the following nominees as Class II directors of the Company to serve until the 2029 Annual Meeting of Stockholders: Joseph G. DoodyWithholdFOR — 7 of 7 John Hancock fundsAgainstElected, 89.9% support
FLAGSTAR BANK, N.A.2026-06-09An advisory vote to approve, on a non-binding basis, compensation of our named executive officers disclosed in the accompanying proxy statement.ForAGAINST — 7 of 7 John Hancock fundsForPassed (calculated), 81.2% support
WSFS FINANCIAL CORPORATION2026-05-14DIRECTOR: David G. TurnerAbstainFOR — 7 of 7 John Hancock fundsAgainst—
CABOT CORPORATION2026-03-12Election of Directors: Raffiq NathooAgainstFOR — 7 of 7 John Hancock fundsAgainstElected, 96.9% support
CABOT CORPORATION2026-03-12Election of Directors: Thierry VanlanckerAgainstFOR — 7 of 7 John Hancock fundsAgainstElected, 94.6% support
ELEMENT SOLUTIONS INC2026-05-04Advisory vote to approve the Company's 2025 executive compensationForAGAINST — 6 of 6 John Hancock fundsForFailed (calculated), 41.4% support
ZURN ELKAY WATER SOLUTIONS CORPORATION2026-04-30DIRECTOR: Emma M. McTagueAbstainFOR — 6 of 6 John Hancock fundsAgainst—
ZURN ELKAY WATER SOLUTIONS CORPORATION2026-04-30DIRECTOR: Peggy N. TroyAbstainFOR — 6 of 6 John Hancock fundsAgainst—
NOBLE CORPORATION PLC2026-04-29Authorization of the Board to Allot Shares without Rights of Pre-Emption.ForAGAINST — 6 of 6 John Hancock fundsForApproved, 81.0% support
NOBLE CORPORATION PLC2026-04-29Authorization of the Board to Allot Shares.ForAGAINST — 6 of 6 John Hancock fundsFor—
MATADOR RESOURCES COMPANY2026-06-11Election of Director Nominees: Reynald A. BaribaultAgainstFOR — 6 of 6 John Hancock fundsAgainstPassed (calculated), 87.0% support
MATADOR RESOURCES COMPANY2026-06-11Election of Director Nominees: Timothy E. ParkerAgainstFOR — 6 of 6 John Hancock fundsAgainstPassed (calculated), 91.6% support
MIAMI INTL HLDGS INC2026-06-16DIRECTOR: Talal Jassim Al-BaharForABSTAIN — 6 of 6 John Hancock fundsFor—
TEXAS CAPITAL BANCSHARES, INC.2026-04-21To elect ten (10) directors - each to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Dale W. TremblayWithholdFOR — 6 of 6 John Hancock fundsAgainstElected, 90.0% support
TEXAS CAPITAL BANCSHARES, INC.2026-04-21To elect ten (10) directors - each to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Thomas E. LongWithholdFOR — 6 of 6 John Hancock fundsAgainstElected, 85.7% support
THE NEW YORK TIMES COMPANY2026-04-22DIRECTOR: Brian P. McAndrewsAbstainFOR — 5 of 5 John Hancock fundsAgainst—
THE NEW YORK TIMES COMPANY2026-04-22DIRECTOR: John W. Rogers, Jr.AbstainFOR — 5 of 5 John Hancock fundsAgainst—
Show all 116
Items 26 to 116.
CompanyMeetingItemThis fundMost John Hancock fundsMgmtResult
CHEWY, INC.2025-07-10DIRECTOR: Sumit SinghForABSTAIN — 5 of 5 John Hancock fundsFor—
PRIMERICA, INC.2026-05-21To elect the following directors: Cynthia N. DayAgainstFOR — 5 of 5 John Hancock fundsAgainstElected, 91.9% support
VALMONT INDUSTRIES, INC.2026-04-27DIRECTOR: Mogens C. BayAbstainFOR — 5 of 5 John Hancock fundsAgainst—
VALMONT INDUSTRIES, INC.2026-04-27DIRECTOR: Ritu FavreAbstainFOR — 5 of 5 John Hancock fundsAgainst—
MSA SAFETY INCORPORATED2026-05-08DIRECTOR: Diane M. PearseAbstainFOR — 5 of 5 John Hancock fundsAgainst—
MSA SAFETY INCORPORATED2026-05-08DIRECTOR: Nishan J. VartanianAbstainFOR — 5 of 5 John Hancock fundsAgainst—
MSA SAFETY INCORPORATED2026-05-08DIRECTOR: William M. LambertAbstainFOR — 5 of 5 John Hancock fundsAgainst—
DUTCH BROS2026-05-13Election of Directors Todd PenegorAgainstFOR — 5 of 5 John Hancock fundsAgainst—
DOXIMITY, INC2025-08-28DIRECTOR: Jeffrey TangneyForABSTAIN — 5 of 5 John Hancock fundsFor—
CRISPR THERAPEUTICS AG2026-06-04Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements.ForAGAINST — 5 of 5 John Hancock fundsForApproved, 69.4% support
FLAGSTAR BANK, N.A.2026-06-09Approval of an Amendment to the Flagstar Bank, N.A. 2020 Omnibus Incentive Plan.ForAGAINST — 5 of 5 John Hancock fundsForPassed (calculated), 85.0% support
FLAGSTAR FINANCIAL, INC.2025-10-15ADJOURNMENT PROPOSAL: To authorize the Board of Directors or an authorized committee thereof to adjourn or postpone the special meeting to a later date, if necessary or appropriate, including adjournments to permit further solicitation of proxies in favor of the merger proposal or the conversion proAgainstFOR — 5 of 5 John Hancock fundsAgainst—
CATHAY GENERAL BANCORP2026-05-183 wordings Election of Class III Directors, to be elected for the term ending 2029. Nelson ChungAgainstFOR — 5 of 5 John Hancock fundsAgainst—
SCORPIO TANKERS INC.2026-05-27Election of Director: Niccolò CameranaWithholdFOR — 5 of 5 John Hancock fundsAgainst—
BANKUNITED, INC.2026-05-21To approve the BankUnited, Inc. Amended and Restated 2023 Omnibus Equity Incentive Plan.ForAGAINST — 5 of 5 John Hancock fundsForPassed (calculated), 60.2% support
H.B. FULLER COMPANY2026-04-16DIRECTOR: Daniel L. FlornessAbstainFOR — 5 of 5 John Hancock fundsAgainst—
H.B. FULLER COMPANY2026-04-16DIRECTOR: Teresa J. RasmussenAbstainFOR — 5 of 5 John Hancock fundsAgainst—
BRIGHTSPRING HEALTH SERVICES, INC.2026-05-212 wordings Election of Class II directors Olivia KirtleyForWITHHOLD — 7 of 8 John Hancock fundsFor—
COMMERCIAL METALS COMPANY2026-01-14Election of three director nominees to serve as Class I directors until the 2029 annual meeting of stockholders Robert S. WetherbeeAgainstFOR — 7 of 8 John Hancock fundsAgainst—
UFP INDUSTRIES, INC.2026-04-22Election of Directors Benjamin J. McLeanAgainstFOR — 7 of 8 John Hancock fundsAgainst—
UFP INDUSTRIES, INC.2026-04-22Election of Directors Mary Tuuk KurasAgainstFOR — 7 of 8 John Hancock fundsAgainst—
OSCAR HEALTH, INC.2026-06-04DIRECTOR: William J. Gassen IIIForABSTAIN — 4 of 4 John Hancock fundsFor—
ELEMENT SOLUTIONS INC2026-05-04Election of Directors E. Stanley O'NealAgainstFOR — 4 of 4 John Hancock fundsAgainst—
ESCO TECHNOLOGIES INC.2026-01-30Election of Directors: Robert J. PhillippyWithholdFOR — 4 of 4 John Hancock fundsAgainstElected, 87.4% support
HUT 8 CORP.2026-06-11To approve an amendment to the Amended and Restated Hut 8 Corp. 2023 Omnibus Incentive Plan.ForAGAINST — 4 of 4 John Hancock fundsForApproved, 84.8% support
HUT 8 CORP.2026-06-11To elect eight directors to serve until our 2027 Annual Meeting of Stockholders. E. Stanley O'NealAgainstFOR — 4 of 4 John Hancock fundsAgainst—
ALLEGRO MICROSYSTEMS, INC.2025-08-07Election of Director for three-year term expiring in 2028: Katsumi KawashimaForWITHHOLD — 4 of 4 John Hancock fundsFor—
ALLEGRO MICROSYSTEMS, INC.2025-08-07Election of Director for three-year term expiring in 2028: Yoshihiro (Zen) SuzukiForWITHHOLD — 4 of 4 John Hancock fundsFor—
SOTERA HEALTH COMPANY2026-05-21Elect the four following Class III director nominees to serve until the 2029 Annual Meeting of Stockholders: Sean L. CunninghamForWITHHOLD — 4 of 4 John Hancock fundsForPassed (calculated), 85.6% support
THE BALDWIN INSURANCE GROUP, INC.2026-06-04DIRECTOR: Ellyn ShookForABSTAIN — 4 of 4 John Hancock fundsFor—
MARRIOTT VACATIONS WORLDWIDE CORPORATION2026-05-15Approval of the Second Amended and Restated Marriott Vacations Worldwide Corporation 2020 Equity Incentive Plan.ForAGAINST — 4 of 4 John Hancock fundsForApproved, 69.0% support
CONSTELLIUM SE2026-05-21Re-appointment of Mr. John Ormerod as a director for a term of three years Mr. John OrmerodAgainstFOR — 4 of 4 John Hancock fundsAgainst—
UNDER ARMOUR, INC.2025-09-03DIRECTOR: Eugene D. SmithAbstainFOR — 4 of 4 John Hancock fundsAgainst—
UNDER ARMOUR, INC.2025-09-03DIRECTOR: Kevin A. PlankForABSTAIN — 4 of 4 John Hancock fundsFor—
UNDER ARMOUR, INC.2025-09-03DIRECTOR: Mohamed A. El-ErianAbstainFOR — 4 of 4 John Hancock fundsAgainst—
ALLEGIANT TRAVEL COMPANY2026-05-08The Allegiant Adjournment Proposal: To give the Allegiant board of directors authority to adjourn the Allegiant special meeting from time to time, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the Allegiant special meeting to apAgainstFOR — 4 of 4 John Hancock fundsAgainst—
HELIOS TECHNOLOGIES, INC.2026-06-15To elect three directors, currently serving on our Board, to serve until the Annual Meeting in 2029, and one director to serve until the Annual Meeting in 2027, whom shall serve until successors are elected and qualified or until an earlier resignation, removal from office or death. Cary ChenandaAgainstFOR — 4 of 4 John Hancock fundsAgainst—
HELIOS TECHNOLOGIES, INC.2026-06-15To elect three directors, currently serving on our Board, to serve until the Annual Meeting in 2029, and one director to serve until the Annual Meeting in 2027, whom shall serve until successors are elected and qualified or until an earlier resignation, removal from office or death. Ian WalshAgainstFOR — 4 of 4 John Hancock fundsAgainst—
HELIOS TECHNOLOGIES, INC.2026-06-15To elect three directors, currently serving on our Board, to serve until the Annual Meeting in 2029, and one director to serve until the Annual Meeting in 2027, whom shall serve until successors are elected and qualified or until an earlier resignation, removal from office or death. Laura Dempsey BrAgainstFOR — 4 of 4 John Hancock fundsAgainst—
OPENDOOR TECHNOLOGIES INC.2025-08-20To approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Special Meeting to approve Proposal 1.AgainstFOR — 4 of 4 John Hancock fundsAgainst—
AGIOS PHARMACEUTICALS, INC.2026-06-18To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified. Cynthia SmithWithholdFOR — 4 of 4 John Hancock fundsAgainst—
AGIOS PHARMACEUTICALS, INC.2026-06-18To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified. Rahul Ballal, Ph.D.WithholdFOR — 4 of 4 John Hancock fundsAgainst—
COVENANT LOGISTICS GROUP, INC.2026-05-13DIRECTOR: W. Miller WelbornAbstainFOR — 4 of 4 John Hancock fundsAgainst—
AIR LEASE CORPORATION2025-12-18Proposal to approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the special meeting to approve the Merger Proposal (the ''Adjournment Proposal'').AgainstFOR — 4 of 4 John Hancock fundsAgainst—
MAPLIGHT THERAPEUTICS, INC.2026-06-23To elect the three Class I Director nominees named in the Proxy Statement to serve until the 2029 annual meeting of our stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal. Martin BablerWithholdFOR — 4 of 4 John Hancock fundsAgainst—
QUAKER HOUGHTON2026-05-13Election of Directors Charlotte C. HenryAgainstFOR — 4 of 4 John Hancock fundsAgainst—
TOWNEBANK2026-05-202 wordings Election of Director For term expiring in 2029: Jeffrey F. BensonWithholdFOR — 4 of 4 John Hancock fundsAgainst—
NEXTRACKER INC.2025-08-18DIRECTOR: Jeffrey GuldnerForABSTAIN — 6 of 7 John Hancock fundsFor—
TTM TECHNOLOGIES, INC.2026-05-07To elect Julie S. England, Philip G. Franklin and Edwin Roks as class II directors. Julie S. EnglandAgainstFOR — 6 of 7 John Hancock fundsAgainst—
POTLATCHDELTIC CORPORATION2026-01-27Proposal 3 - The PotlatchDeltic adjournment proposal: A proposal to adjourn the special meeting from time to time, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the special meeting to approve the PotlatchDeltic merger agreement AgainstFOR — 7 of 9 John Hancock fundsAgainst—
10X GENOMICS, INC.2026-06-04Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatioForAGAINST — 3 of 3 John Hancock fundsFor—
PRAXIS PRECISION MEDICINES, INC.2026-06-10To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified. William YoungForWITHHOLD — 5 of 6 John Hancock fundsFor—
IMMUNOVANT, INC.2025-08-27DIRECTOR: Douglas HughesForABSTAIN — 3 of 3 John Hancock fundsFor—
IMMUNOVANT, INC.2025-08-27DIRECTOR: Jacob BauerAbstainFOR — 3 of 3 John Hancock fundsAgainst—
RUSH ENTERPRISES, INC.2026-05-19DIRECTOR: Dr. Kennon H. GuglielmoForABSTAIN — 5 of 6 John Hancock fundsFor—
RUSH ENTERPRISES, INC.2026-05-19DIRECTOR: Raymond J. ChessForABSTAIN — 5 of 6 John Hancock fundsFor—
RUSH ENTERPRISES, INC.2026-05-19DIRECTOR: Troy A. ClarkeForABSTAIN — 5 of 6 John Hancock fundsFor—
CRISPR THERAPEUTICS AG2026-06-04Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan.ForAGAINST — 3 of 3 John Hancock fundsForApproved, 88.1% support
CRISPR THERAPEUTICS AG2026-06-04Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2025 Compensation Report - Binding vote on maximum equity for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholForAGAINST — 3 of 3 John Hancock fundsFor—
CRISPR THERAPEUTICS AG2026-06-04Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2025 Compensation Report - Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of sharehoForAGAINST — 3 of 3 John Hancock fundsFor—
CRISPR THERAPEUTICS AG2026-06-04Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2025 Compensation Report - Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027.ForAGAINST — 3 of 3 John Hancock fundsFor—
CRISPR THERAPEUTICS AG2026-06-04Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2025 Compensation Report - Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026.ForAGAINST — 3 of 3 John Hancock fundsFor—
CRISPR THERAPEUTICS AG2026-06-04Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2025 Compensation Report - Non-binding advisory vote on the 2025 Compensation Report.ForAGAINST — 3 of 3 John Hancock fundsFor—
FIGS, INC.2026-06-03DIRECTOR: Heather HassonAbstainFOR — 3 of 3 John Hancock fundsAgainst—
FIGS, INC.2026-06-03DIRECTOR: Kenneth LinAbstainFOR — 3 of 3 John Hancock fundsAgainst—
SMARTSTOP SELF STORAGE REIT, INC.2026-06-23The election of six directors, each to serve until the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualifies. David J. MuellerWithholdFOR — 3 of 3 John Hancock fundsAgainst—
SMARTSTOP SELF STORAGE REIT, INC.2026-06-23The election of six directors, each to serve until the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualifies. Harold "Skip" PerryWithholdFOR — 3 of 3 John Hancock fundsAgainst—
SMARTSTOP SELF STORAGE REIT, INC.2026-06-23The election of six directors, each to serve until the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualifies. Timothy S. MorrisWithholdFOR — 3 of 3 John Hancock fundsAgainst—
SAVERS VALUE VILLAGE, INC.2026-06-10DIRECTOR: Kristy PipesForABSTAIN — 3 of 3 John Hancock fundsFor—
SAFEHOLD INC.2026-05-14Approval of proposed amendment to Amended and Restated 2009 Long Term Incentive PlanForAGAINST — 3 of 3 John Hancock fundsForApproved, 90.5% support
ROOT, INC.2026-06-03To elect three Class III directors, Lawrence Hilsheimer, Alexander Timm and Douglas Ulman, each to hold office until our Annual Meeting of Stockholders in 2029. Alexander TimmForAGAINST — 3 of 3 John Hancock fundsFor—
CECO ENVIRONMENTAL CORP.2026-05-27Adjournment Proposal. To APPROVE a proposal to adjourn the CECO annual meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes to approve the CECO stock issuance proposal at the time of the CECO annual meeting.AgainstFOR — 3 of 3 John Hancock fundsAgainst—
COMMERCIAL BANCGROUP, INC.2026-04-27Election of three Class I directors to serve until the 2029 annual meeting of company shareholders and thereafter until the election and qualification of their successors or a decrease in the number of directors. Sam A. Mars IIIForWITHHOLD — 3 of 3 John Hancock fundsFor—
PERMIAN RESOURCES CORPORATION2026-05-19To approve the First Amendment to the Permian Resources Corporation 2023 Long Term Incentive Plan.ForAGAINST — 8 of 11 John Hancock fundsForPassed (calculated), 71.8% support
CONCENTRA GROUP HOLDINGS PARENT INC2026-04-30Elect three Class II directors, each for a term of three years or until their respective successors have been elected and qualified. Marc R. WatkinsForAGAINST — 6 of 8 John Hancock fundsFor—
CYTOKINETICS, INCORPORATED2026-05-27Election of Class I Directors for terms expiring in 2029. Wendell Wierenga, Ph.D.WithholdFOR — 7 of 10 John Hancock fundsAgainst—
PBF ENERGY INC.2026-04-28Election of Directors Lawrence M. ZiembaForAGAINST — 4 of 5 John Hancock fundsFor—
INTAPP, INC2025-11-18DIRECTOR: Beverly AllenForABSTAIN — 4 of 5 John Hancock fundsFor—
INTAPP, INC2025-11-18DIRECTOR: Marie WieckForABSTAIN — 4 of 5 John Hancock fundsFor—
ELEMENT SOLUTIONS INC2026-05-04Election of Directors Ian G.H. AshkenForAGAINST — 3 of 4 John Hancock fundsFor—
ELEMENT SOLUTIONS INC2026-05-04Election of Directors Michael F. GossForAGAINST — 3 of 4 John Hancock fundsFor—
ELEMENT SOLUTIONS INC2026-05-04Election of Directors Susan W. SofronasForAGAINST — 3 of 4 John Hancock fundsFor—
REYNOLDS CONSUMER PRODUCTS INC2026-04-29Election of Directors Rolf StanglForWITHHOLD — 3 of 4 John Hancock fundsFor—
REYNOLDS CONSUMER PRODUCTS INC2026-04-29Election of Directors Scott HuckinsForWITHHOLD — 3 of 4 John Hancock fundsFor—
IMMUNOME INC.2026-06-09To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal. James BoylanForWITHHOLD — 3 of 4 John Hancock fundsFor—
BICARA THERAPEUTICS INC.2026-06-09To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal. Carolyn Ng, Ph.D.ForWITHHOLD — 3 of 4 John Hancock fundsFor—
BICARA THERAPEUTICS INC.2026-06-09To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal. Christopher Bowden, M.D.ForWITHHOLD — 3 of 4 John Hancock fundsFor—
MAPLIGHT THERAPEUTICS, INC.2026-06-23To elect the three Class I Director nominees named in the Proxy Statement to serve until the 2029 annual meeting of our stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal. George PavlovForWITHHOLD — 3 of 4 John Hancock fundsFor—
RBC BEARINGS INCORPORATED2025-09-04Election of Directors Edward D. StewartAgainstFOR — 5 of 9 John Hancock fundsAgainst—
VAXCYTE, INC.2026-06-15DIRECTOR: Halley Gilbert, J.D.ForABSTAIN — 5 of 9 John Hancock fundsFor—
VAXCYTE, INC.2026-06-15DIRECTOR: Olivier Brandicourt MDForABSTAIN — 5 of 9 John Hancock fundsFor—

Download all 116 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 90.6% of this fund’s 1,835 such votes could be given a sector; the other 172 (9.4%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance41800.0%
Consumer Discretionary31630.9%
Industrials26241.5%
Health Care19200.0%
Technology12810.8%
Real Estate11900.0%
Energy9200.0%
Utilities9011.1%
Consumer Staples2400.0%
Miscellaneous1000.0%
Basic Materials600.0%
Telecommunications600.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1,2892
Say-on-Pay2062
Audit-related1990
Corporate Governance613
Compensation540
Capital Structure310
Other110
Shareholder Rights and Defenses41
Extraordinary Transactions30
Other Social Issues20

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
PINNACLE FINANCIAL PARTNERS INCMay 21, 2026$3M190
COLUMBIA BANKING SYSTEM, INC.May 14, 2026$2M140
VIAVI SOLUTIONS INC.November 12, 2025$2M130
COLUMBIA BANKING SYSTEM,INC.July 21, 2025$2M20
CURBLINE PROPERTIES CORP.May 7, 2026$2M50
PBF ENERGY INC.April 28, 2026$2M140
BRIGHTSPRING HEALTH SERVICES, INC.May 21, 2026$2M50
HA SUSTAINABLE INFRASTRUCTURE CAPITALJune 3, 2026$2M120

Notable votes against management

MeetingCompanyProposalFundMgmt
May 20, 2026RELIANCE, INC.To consider a stockholder proposal requiring any director who fails to receive a majority vote to leave the board of directors within nine months. Shareholder proposalAgainstFor
May 14, 2026OGE ENERGY CORP.Shareholder Proposal Regarding Simple Majority Vote. Shareholder proposalForAgainst
May 6, 2026ENTEGRIS, INC.Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposalAgainstFor
December 15, 2025UNIFIRST CORPORATIONCOMPANY NOMINEE OPPOSED BY ENGINE: Joseph M. NowickiWithholdFor
December 15, 2025UNIFIRST CORPORATIONCOMPANY NOMINEE OPPOSED BY ENGINE: Steven S. SintrosWithholdFor
March 9, 2026SANMINA CORPORATIONTo consider and vote upon the stockholder proposal entitled ''Independent Board Chairman,'' requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposalAgainstFor
September 3, 2025UNDER ARMOUR, INC.To vote on a stockholder proposal, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
May 21, 2026CONSTELLIUM SEAdvisory (non-binding) vote to hold an advisory (non-binding vote) on the compensation of the Company's named executive officers every two yearsAgainstFor
May 21, 2026CONSTELLIUM SEAdvisory (non-binding) vote to hold an advisory (non-binding vote) on the compensation of the Company's named executive officers every three yearsAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (2 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

1,861 ballot items at 199 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Small Company Value Trust (JAEPX) voted at 199 shareholder meetings of 196 companies, on 1,861 ballot items in all. Where management made a recommendation, the fund followed it on 96.8% of the items and voted against it 9 times. Its most frequent area of disagreement was corporate governance (3 of its votes against management). It voted on 5 shareholder proposals. It voted FOR the board's own proposals more often than John Hancock's funds as a whole (91.8% against 90.1%). It voted differently from most John Hancock funds on 116 items. 2 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of John Hancock’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.